Results 341 to 349 of about 131,451 (349)

<p>Management of recurrent nasopharyngeal carcinoma: current perspectives</p>

OncoTargets and Therapy, 2019
Francesco Perri, Franco Ionna, Francesco Longo   +2 more
exaly  

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

Ca-A Cancer Journal for Clinicians
Ji-Bin Li, Ling-Long Tang, Cheng-Long Huang   +2 more
exaly  

Dose–response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: A study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)

Radiotherapy and Oncology, 2006
Anne W M Lee, Benny Zee, Anthony T C Chan   +2 more
exaly  

Treatment adaptation based on response to induction chemotherapy in nasopharyngeal carcinoma: An evolving landscape

Ca-A Cancer Journal for Clinicians
Annie W Chan
exaly  

Genetic and epigenetic changes in nasopharyngeal carcinoma

Seminars in Cancer Biology, 2002
Kwok-Wai Lo
exaly  

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study

Annals of Oncology, 2002
exaly  

The aetiology of nasopharyngeal carcinoma

Clinical Otolaryngology, 2001
exaly  

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

Annals of Oncology, 2002
exaly  

Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma

Annals of Oncology, 2013
exaly